Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavlo Gilchuk

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Investigation|July 17, 2012
Viral acute lower respiratory infections impair CD8+ T cells through PD-1John J Erickson, Pavlo Gilchuk, Andrew K Hastings, et al.
Plos Pathogens|August 24, 2018
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan capPhilipp A Ilinykh, Rodrigo I Santos, Bronwyn M Gunn, et al.
Nature Communications|April 19, 2019
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalkLiam B King, Brandyn R West, Crystal L Moyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictionsNina G Bozhanova, Amandeep K Sangha, Alexander M Sevy, et al.
ACS Nano|September 26, 2019
Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8<sup>+</sup> Lung-Resident Memory T CellsFrances C Knight, Pavlo Gilchuk, Amrendra Kumar, et al.
Proteomics. Clinical Applications|January 16, 2016
Viral infection causes a shift in the self peptide repertoire presented by human MHC class I moleculesCharles T Spencer, Jelena S Bezbradica, Mireya G Ramos, et al.
The Journal of Infectious Diseases|July 9, 2018
Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman PrimatesPavlo Gilchuk, Chad E Mire, Joan B Geisbert, et al.
Communications Biology|July 17, 2024
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement systemPhilipp A Ilinykh, Kai Huang, Bronwyn M Gunn, et al.
Communications Biology|July 31, 2024
Author Correction: Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement systemPhilipp A Ilinykh, Kai Huang, Bronwyn M Gunn, et al.
Journal of Virology|December 7, 2018
Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus VaccineJ Brian Kimble, Delphine C Malherbe, Michelle Meyer, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Investigation|July 17, 2012
Viral acute lower respiratory infections impair CD8+ T cells through PD-1John J Erickson, Pavlo Gilchuk, Andrew K Hastings, et al.
Plos Pathogens|August 24, 2018
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan capPhilipp A Ilinykh, Rodrigo I Santos, Bronwyn M Gunn, et al.
Nature Communications|April 19, 2019
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalkLiam B King, Brandyn R West, Crystal L Moyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictionsNina G Bozhanova, Amandeep K Sangha, Alexander M Sevy, et al.
ACS Nano|September 26, 2019
Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8<sup>+</sup> Lung-Resident Memory T CellsFrances C Knight, Pavlo Gilchuk, Amrendra Kumar, et al.
Proteomics. Clinical Applications|January 16, 2016
Viral infection causes a shift in the self peptide repertoire presented by human MHC class I moleculesCharles T Spencer, Jelena S Bezbradica, Mireya G Ramos, et al.
The Journal of Infectious Diseases|July 9, 2018
Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman PrimatesPavlo Gilchuk, Chad E Mire, Joan B Geisbert, et al.
Communications Biology|July 17, 2024
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement systemPhilipp A Ilinykh, Kai Huang, Bronwyn M Gunn, et al.
Communications Biology|July 31, 2024
Author Correction: Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement systemPhilipp A Ilinykh, Kai Huang, Bronwyn M Gunn, et al.
Journal of Virology|December 7, 2018
Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus VaccineJ Brian Kimble, Delphine C Malherbe, Michelle Meyer, et al.
Pageof 8